We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know
Read MoreHide Full Article
Tilray Brands, Inc. (TLRY - Free Report) ended the recent trading session at $1.25, demonstrating a -9.42% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.69%. Meanwhile, the Dow experienced a drop of 0.55%, and the technology-dominated Nasdaq saw a decrease of 0.82%.
Coming into today, shares of the company had gained 127.05% in the past month. In that same time, the Medical sector gained 5.6%, while the S&P 500 gained 3.79%.
The investment community will be closely monitoring the performance of Tilray Brands, Inc. in its forthcoming earnings report. In that report, analysts expect Tilray Brands, Inc. to post earnings of -$0.03 per share. This would mark year-over-year growth of 25%. At the same time, our most recent consensus estimate is projecting a revenue of $206.83 million, reflecting a 3.39% rise from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of -$0.11 per share and a revenue of $877.28 million, demonstrating changes of -1200% and +6.81%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Tilray Brands, Inc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Tilray Brands, Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 94, this industry ranks in the top 39% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Tilray Brands, Inc. (TLRY) Dips More Than Broader Market: What You Should Know
Tilray Brands, Inc. (TLRY - Free Report) ended the recent trading session at $1.25, demonstrating a -9.42% change from the preceding day's closing price. The stock's performance was behind the S&P 500's daily loss of 0.69%. Meanwhile, the Dow experienced a drop of 0.55%, and the technology-dominated Nasdaq saw a decrease of 0.82%.
Coming into today, shares of the company had gained 127.05% in the past month. In that same time, the Medical sector gained 5.6%, while the S&P 500 gained 3.79%.
The investment community will be closely monitoring the performance of Tilray Brands, Inc. in its forthcoming earnings report. In that report, analysts expect Tilray Brands, Inc. to post earnings of -$0.03 per share. This would mark year-over-year growth of 25%. At the same time, our most recent consensus estimate is projecting a revenue of $206.83 million, reflecting a 3.39% rise from the equivalent quarter last year.
For the full year, the Zacks Consensus Estimates project earnings of -$0.11 per share and a revenue of $877.28 million, demonstrating changes of -1200% and +6.81%, respectively, from the preceding year.
Investors should also note any recent changes to analyst estimates for Tilray Brands, Inc. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the business and profitability.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has remained steady. Tilray Brands, Inc. currently has a Zacks Rank of #3 (Hold).
The Medical - Products industry is part of the Medical sector. With its current Zacks Industry Rank of 94, this industry ranks in the top 39% of all industries, numbering over 250.
The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.